Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

Smart Nursing AI Agent for Health Self-Management

NCT07761663 · tracked via the Priya Life Science Taiwan tracker
Phase
Not applicable
Started
2026-08-05
Last updated
2026-08-12

Condition(s) studied

Mobility LimitationsCommunity-dwelling Older AdultsMiddle-aged and Older Adults

Investigational drug(s) / intervention(s)

Smart Nursing AI Agent

Smart Nursing AI Agent: Smart Nursing AI Agent which provides daily interaction, reminder systems, personalized recommendations, activity monitoring, goal setting, motivational support, and health self-management education.

Study summary

This study aims to develop and evaluate a smart nursing AI agent to support health self-management among middle-aged and older patients, and further to examine its effectiveness in home care and health self-management. The goal is to propose innovative strategies for middle-aged and older care that enhance the quality of home care and strengthen patients' health self-management abilities. A randomized controlled trial design will be adopted, with a planned enrollment of 102 participants. Participants will be randomly assigned to either the experimental group or the control group. Regardless of group assignment, their routine medical care will remain unchanged. Both groups will participate in the study for 12 weeks (8 weeks of intervention and 4 weeks of follow-up), with identical frequency and number of follow-ups, interviews, and evaluations. The experimental group will receive an 8 week intervention using the smart nursing AI agent care model, which provides daily interaction, reminder systems, personalized recommendations, activity monitoring, goal setting, motivational support, and health self-management education. The control group will continue with the existing standard health education approach. Data collection will include demographic information, medical history, physiological indicators, functional activity measures (e.g., steps, distance, exercise duration), sarcopenia screening, nutritional assessment, physical activity levels, health self-management ability, health literacy, quality of life, and digital usage behaviors. Statistical analyses will be conducted to evaluate the effectiveness, feasibility, and acceptability of the intervention.

Eligibility

Sex
ALL
Min age
50 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Patients aged 50 years or older who present with mobility limitations such as gait instability, sarcopenia, joint degeneration, chronic pain, or functional decline 2. Able to ambulate 3. Alert and oriented Exclusion Criteria: 1. Terminal cancer or major illness with a prognosis of left 6 months 2. Moderate to severe dementia or language expression disorders 3. Individuals with significant audiovisual impairments that prevent AI conversation 4. Unable to complete walking tests on their own

Primary outcome measure(s)

  • Change from baseline in Sarcopenia (SARC-F) questionnaire score at 3 months — Baseline and 3 months
    The SARC-F questionnaire is a rapid, 5-question clinical screening tool. The tool evaluates five key components of functional decline (Strength, Assistance with walking, Rise from a chair, Climb stairs, Falls). For each question, patients score between 0 (None) and 2 (A lot or unable or ≧ 4 falls) depending on the severity of their limitation.
  • Change from baseline in Mini Nutritional Assessment (MNA) score at 3 months — Baseline and 3 months
    The Mini Nutritional Assessment (MNA) is a validated, 6-question screening tool used to quickly identify adults aged 65 and older who are malnourished or at risk of malnutrition.The tool uses a scoring system with a maximum of 14 points. The score determines the individual's nutritional category:12 to 14 points is normal nutritional status, 8 to 11 points is risk of malnutrition, and 0 to 7 points is malnourished.
  • Change from baseline in International Physical Activity Questionnaire-Short Form (IPAQ-SF) score (MET-minutes/week) at 3 months — Baseline and 3 months
    The International Physical Activity Questionnaire-Short Form (IPAQ-SF) is a widely used, 7-item survey designed to measure health-related physical activity and sedentary behavior. It evaluates time spent walking, as well as moderate and vigorous-intensity activities over the last 7 days. The score is expressed as metabolic equivalent tasks (MET)-minutes per week, calculated by multiplying the MET level of an activity (walking, moderate, or vigorous) by its duration and frequency. Higher MET-minutes/week values indicate higher levels of physical activity.
  • Change from baseline in daily step count at 1 and 2 months — Baseline, 1 and 2 Months
    This measure assesses the physical activity level of participants based on the average number of daily steps. Data are automatically tracked and collected via the platform's backend system using the designated JoiiCare mobile application.
  • Change from baseline in Partners in Health (PIH) scale score at 1 and 2 months — Baseline, 1 and 2 Months
    The PIH scale has demonstrated potential to be a reliable and valid measure of chronic condition self-management. It comprises 12 items, with response options ranging from 0 (very little or never) to 8 (always or very well), and a total score ranging from 0 to 96 points. Higher scores indicate better self-management ability / a higher level of self-management.
  • Change from baseline in eHealth Literacy Scale (eHEALS) score at 1 and 2 months — Baseline, 1 and 2 Months
    The eHEALS is an 8-item measure of eHealth literacy designed to assess consumers' combined knowledge, comfort, and perceived skills in finding, evaluating, and applying electronic health information to health problems. It comprises 8 items, with response options ranging from 1 (Strongly Disagree) to 5 (Strongly Agree). The total score ranges from 8 to 40 points. Higher scores indicate a higher level of perceived eHealth literacy.
  • Change from baseline in EQ-5D index score at 1 and 2 months — Baseline, 1 and 2 Months
    The EuroQol 5-Dimension (EQ-5D) index score assesses health-related quality of life across 5 dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The health states are converted into a single index score using a standard country-specific value set. The score typically ranges from less than 0 (where 0 represents death and 1 represents perfect health), with higher scores indicating a better health state.
  • Change from baseline in daily walking distance (meters) at 1 and 2 months — Baseline, 1 and 2 Months
    This measure evaluates the average physical distance covered by participants per day. Data are automatically tracked and retrieved from the platform's backend database via the JoiiCare mobile application.
  • Change from baseline in daily exercise duration (minutes) at 1 and 2 months — Baseline, 1 and 2 Months
    This measure records the average amount of time (in minutes) participants spend engaging in exercise daily. Data are captured and compiled through the platform's backend system based on the JoiiCare mobile application activity logs.
  • Change from baseline in EQ Visual Analog Scale (EQ-VAS) score at 1 and 2 months — Baseline, 1 and 2 Months
    The EQ Visual Analog Scale (EQ-VAS) records the participant's self-rated health on a vertical visual analog scale. The score ranges from 0 to 100, where 0 represents the worst health you can imagine, and 100 represents the best health you can imagine.

Trial sites (1)

FacilityCityRegionStatus
National Yang Ming Chiao Tung University Nursing Building Room 504A Taipei, Nursing Building, No.155, Sec.2, Li-Nong Street,, Taiwan, 112 Taipei Taiwan
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07761663 on ClinicalTrials.gov ↗ ← All trials in Taiwan